Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
12/10/2026 14:16
BRIEF-Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance Oct 12 (Reuters) - Bausch Health Companies Inc. BHC.TO:
BAUSCH + LOMB AND BAUSCH HEALTH ANNOUNCE APPOINTMENT OF THOMAS J. APPIO AS INTERIM BAUSCH + LOMB CEO, EXPECT TO RAISE FULL-YEAR 2026 GUIDANCE
BAUSCH + LOMB - BRENT SAUNDERS TO DEPART AS CEO OF BAUSCH + LOMB
BAUSCH + LOMB - EXPECT TO RAISE FULL-YEAR 2026 ADJUSTED EBITDA EXCLUDING BOUGHT IPR&D GUIDANCE
Source text: ID:nBw7rjGMDa
Further company coverage: BHC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data